Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Goodwill (2019 - 2026)

Biodesix filings provide 8 years of Goodwill readings, the most recent being $15.0 million for Q1 2026.

  • On a quarterly basis, Goodwill changed 0.0% to $15.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $15.0 million, a 0.0% change, with the full-year FY2025 number at $15.0 million, changed 0.0% from a year prior.
  • Goodwill hit $15.0 million in Q1 2026 for Biodesix, roughly flat from $15.0 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $15.0 million in Q1 2022 to a low of $15.0 million in Q1 2022.
  • Median Goodwill over the past 5 years was $15.0 million (2022), compared with a mean of $15.0 million.
  • The widest YoY moves for Goodwill: up 0.0% in 2022, down 0.0% in 2022.
  • Biodesix's Goodwill stood at $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025, then changed by 0.0% to $15.0 million in 2026.
  • The last three reported values for Goodwill were $15.0 million (Q1 2026), $15.0 million (Q4 2025), and $15.0 million (Q3 2025) per Business Quant data.